| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An oral B subunit: whole cell vaccine against cholera
|
Holmgren, J.
|
|
1992
|
10 |
13 |
p. 911-914
4 p.
|
artikel
|
| 2 |
Availability of quality vaccines: policies of a non-government organization
|
Poore, Peter
|
|
1992
|
10 |
13 |
p. 958-960
3 p.
|
artikel
|
| 3 |
Availability of quality vaccines: The industrial point of view
|
Vandersmissen, Walter
|
|
1992
|
10 |
13 |
p. 955-957
3 p.
|
artikel
|
| 4 |
Availability of vaccines of an assured quality
|
Magrath, D.I.
|
|
1992
|
10 |
13 |
p. 952-953
2 p.
|
artikel
|
| 5 |
Benefits and costs of vaccination
|
Dejonghe, P.
|
|
1992
|
10 |
13 |
p. 936-939
4 p.
|
artikel
|
| 6 |
Biostatistical manual (BIOSTAT) for potency control and for evaluation of effectiveness of the WHO-EPI vaccines: software for personal computers
|
Lugosi, Laszlo
|
|
1992
|
10 |
13 |
p. 961-963
3 p.
|
artikel
|
| 7 |
Calendar
|
|
|
1992
|
10 |
13 |
p. 966-
1 p.
|
artikel
|
| 8 |
Compositions containing protein antigen recognized by monoclonal antibody H23; for mamma carcinoma therapy; also vaccinia virus compositions for use in recombinant vaccine
|
|
|
1992
|
10 |
13 |
p. 965-
1 p.
|
artikel
|
| 9 |
Contribution to hepatitis B prevention
|
Stephenne, Jean
|
|
1992
|
10 |
13 |
p. 900-903
4 p.
|
artikel
|
| 10 |
Contribution to rabies prevention
|
Sureau, P.
|
|
1992
|
10 |
13 |
p. 896-899
4 p.
|
artikel
|
| 11 |
Editorial
|
|
|
1992
|
10 |
13 |
p. 891-
1 p.
|
artikel
|
| 12 |
EPI for the 1990s
|
Kim-Farley, R.J.
|
|
1992
|
10 |
13 |
p. 940-948
9 p.
|
artikel
|
| 13 |
European vaccine manufacturers: present status and future trends
|
Baudrihaye, N.
|
|
1992
|
10 |
13 |
p. 893-895
3 p.
|
artikel
|
| 14 |
Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens
|
Glück, Reinhard
|
|
1992
|
10 |
13 |
p. 915-919
5 p.
|
artikel
|
| 15 |
Introduction
|
Furminger, I.
|
|
1992
|
10 |
13 |
p. 892-
1 p.
|
artikel
|
| 16 |
New chronic fatigue immunodysfunction syndrome-associated CAV virus; used as a vaccine or for diagnosis, therapy and prophylaxis of infection; DNA probe, DNA primer construction; DNA sequence
|
|
|
1992
|
10 |
13 |
p. 964-
1 p.
|
artikel
|
| 17 |
New peptides common to Mycoplasma adhesion molecule and HIV proteins; Mycoplasma genitalium, Mycoplasma pneumoniae or Mycoplasma pirum adhesin, homologous with HIV virus glycoprotein, useful in vaccine against AIDS, Mycoplasma sp. infection, therapy, diagnosis
|
|
|
1992
|
10 |
13 |
p. 964-
1 p.
|
artikel
|
| 18 |
Nucleic acid encoding chicken anaemia virus; fowl-anaemia virus attenuation or antigen gene cloning and expression for use as recombinant vaccine or diagnostic agent
|
|
|
1992
|
10 |
13 |
p. 964-
1 p.
|
artikel
|
| 19 |
Preventive strategies against poliomyelitis
|
Swartz, T.A.
|
|
1992
|
10 |
13 |
p. 904-908
5 p.
|
artikel
|
| 20 |
Recombinant baculovirus e.g. Autographa californica nuclear-polyhedrosis virus; used for pseudorabies virus glycoprotein-III gene cloning and expression in a Spodoptera frugiperda Sf21AE insect cell culture for use as a recombinant vaccine or diagnostic
|
|
|
1992
|
10 |
13 |
p. 965-
1 p.
|
artikel
|
| 21 |
Recombinant plasmid expressing secretory truncated glycoprotein of Varicella-zoster virus in mammal cell culture; use as vaccine for chicken pox or shingles, and use of monoclonal antibody in diagnosis
|
|
|
1992
|
10 |
13 |
p. 964-
1 p.
|
artikel
|
| 22 |
Strategies for the development of an antimalarial vaccine
|
Enders, Burkhard
|
|
1992
|
10 |
13 |
p. 920-927
8 p.
|
artikel
|
| 23 |
The Children's Vaccine Initiative and vaccine supply: the role of the public sector
|
van Noort, R.B.J.C.
|
|
1992
|
10 |
13 |
p. 909-910
2 p.
|
artikel
|
| 24 |
The cold chain from manufacturer to vaccinator: experiments and experiences
|
von Hedenström, Michael
|
|
1992
|
10 |
13 |
p. 949-951
3 p.
|
artikel
|
| 25 |
The concept of herd immunity and the design of community-based immunization programmes
|
Anderson, Roy M.
|
|
1992
|
10 |
13 |
p. 928-935
8 p.
|
artikel
|
| 26 |
The countries' point of view
|
Schatzmayr, Hermann G.
|
|
1992
|
10 |
13 |
p. 954-
1 p.
|
artikel
|
| 27 |
Vaccine against equine-herpes virus; contains horse-herpes virus glycoprotein and/or lectin complex, or extracellular virion
|
|
|
1992
|
10 |
13 |
p. 965-
1 p.
|
artikel
|
| 28 |
Vaccine against varicella-zoster virus; recombinant vaccine or diagnostic agent preparation and DNA sequence
|
|
|
1992
|
10 |
13 |
p. 964-
1 p.
|
artikel
|
Tijdschrift beschrijving